290 related articles for article (PubMed ID: 16810343)
1. Diabetes, insulin, and risk of cancer.
Schiel R; Beltschikow W; Steiner T; Stein G
Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):169-75. PubMed ID: 16810343
[TBL] [Abstract][Full Text] [Related]
2. Risk of malignancies in patients with insulin-treated diabetes mellitus: results of a population-based trial with 10-year follow-up (JEVIN).
Schiel R; Müller UA; Braun A; Stein G; Kath R
Eur J Med Res; 2005 Aug; 10(8):339-44. PubMed ID: 16131475
[TBL] [Abstract][Full Text] [Related]
3. Impaired glucose metabolism in colorectal cancer.
Ehrmann-Jósko A; Siemińska J; Górnicka B; Ziarkiewicz-Wróblewska B; Ziółkowski B; Muszyński J
Scand J Gastroenterol; 2006 Sep; 41(9):1079-86. PubMed ID: 16938722
[TBL] [Abstract][Full Text] [Related]
4. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas.
Giovannucci E; Michaud D
Gastroenterology; 2007 May; 132(6):2208-25. PubMed ID: 17498513
[TBL] [Abstract][Full Text] [Related]
5. [Diabetes, insulin, insulin analogues, and cancer].
Müssig K; Staiger H; Kantartzis K; Fritsche A; Kanz L; Häring HU
Dtsch Med Wochenschr; 2010 May; 135(18):924-9. PubMed ID: 20425680
[TBL] [Abstract][Full Text] [Related]
6. Diabetes mellitus type 2 - an independent risk factor for cancer?
Grote VA; Becker S; Kaaks R
Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):4-8. PubMed ID: 20127570
[TBL] [Abstract][Full Text] [Related]
7. Review article: steatosis, the metabolic syndrome and cancer.
Bugianesi E
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():40-3. PubMed ID: 16225471
[TBL] [Abstract][Full Text] [Related]
8. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
9. Type 2 diabetes and cancer: what is the connection?
Cannata D; Fierz Y; Vijayakumar A; LeRoith D
Mt Sinai J Med; 2010; 77(2):197-213. PubMed ID: 20309918
[TBL] [Abstract][Full Text] [Related]
10. Diabetes and the risk of pancreatic cancer.
Gullo L; Pezzilli R; Morselli-Labate AM;
N Engl J Med; 1994 Jul; 331(2):81-4. PubMed ID: 8208269
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic carcinoma: differences between patients with or without diabetes mellitus.
Girelli CM; Reguzzoni G; Limido E; Savastano A; Rocca F
Recenti Prog Med; 1995 Apr; 86(4):143-6. PubMed ID: 7617956
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological aspects of neoplasms in diabetes.
Nicolucci A
Acta Diabetol; 2010 Jun; 47(2):87-95. PubMed ID: 20376506
[TBL] [Abstract][Full Text] [Related]
13. Effect of etanercept on insulin secretion and insulin sensitivity in a randomized trial with psoriatic patients at risk for developing type 2 diabetes mellitus.
Martínez-Abundis E; Reynoso-von Drateln C; Hernández-Salazar E; González-Ortiz M
Arch Dermatol Res; 2007 Nov; 299(9):461-5. PubMed ID: 17726611
[TBL] [Abstract][Full Text] [Related]
14. [Serum concentration of insulin, C-peptide and insulin-like growth factor I in patients with colon adenomas and colorectal cancer].
Kaczka A; Kumor A; Pietruczuk M; Małecka-Panas E
Pol Merkur Lekarski; 2007 May; 22(131):373-5. PubMed ID: 17679371
[TBL] [Abstract][Full Text] [Related]
15. [Insulin treatment is of value--also in type 2 diabetes].
Birkeland KI; Vaaler S; Hanssen KF
Tidsskr Nor Laegeforen; 1996 Apr; 116(10):1233-5. PubMed ID: 8658397
[TBL] [Abstract][Full Text] [Related]
16. Diabetes mellitus as a novel risk factor for gastrointestinal malignancies.
Herrigel DJ; Moss RA
Postgrad Med; 2014 Oct; 126(6):106-18. PubMed ID: 25414939
[TBL] [Abstract][Full Text] [Related]
17. Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes.
Govindarajan R; Ratnasinghe L; Simmons DL; Siegel ER; Midathada MV; Kim L; Kim PJ; Owens RJ; Lang NP
J Clin Oncol; 2007 Apr; 25(12):1476-81. PubMed ID: 17442990
[TBL] [Abstract][Full Text] [Related]
18. Diabetes and the risk of prostate cancer: the role of diabetes treatment and complications.
Velicer CM; Dublin S; White E
Prostate Cancer Prostatic Dis; 2007; 10(1):46-51. PubMed ID: 17033617
[TBL] [Abstract][Full Text] [Related]
19. Hyperproinsulinemia segregates young adult patients with newly diagnosed autoimmune (type 1) and non-autoimmune (type 2) diabetes.
Bolinder J; Fernlund P; Borg H; Arnqvist HJ; Björk E; Blohmé G; Eriksson JW; Nyström L; Ostman J; Sundkvist G
Scand J Clin Lab Invest; 2005; 65(7):585-94. PubMed ID: 16271990
[TBL] [Abstract][Full Text] [Related]
20. Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study.
Halimi JM; Bonnet F; Lange C; Balkau B; Tichet J; Marre M;
J Hypertens; 2008 Nov; 26(11):2198-206. PubMed ID: 18854761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]